Background: With the growing rate of obesity and associated chronic conditions in China, there is a need to assess health economic burdens examine effectiveness pharmaceutical, medical, comprehensive weight-loss interventions.Areas covered: This article reviewed publications retrieved from PubMed Google Scholar during 2010–2020 on pharmacoeconomic studies related overweight China. We identified...